Key facts
- This page summarizes Matthew Joseph Eckler's Form 4 filing for PMV Pharmaceuticals, Inc. (PMVP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 05 Oct 2026, 16:14.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Shares subject to the option vest in 36 equal monthly installments beginning on November 1, 2026.